Chemed Debt to Equity Ratio 2010-2024 | CHE

Current and historical debt to equity ratio values for Chemed (CHE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Chemed debt/equity for the three months ending March 31, 2024 was 0.00.
Chemed Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.54B $1.18B 0.46
2023-12-31 $0.56B $1.11B 0.51
2023-09-30 $0.54B $1.02B 0.53
2023-06-30 $0.55B $0.95B 0.58
2023-03-31 $0.55B $0.88B 0.63
2022-12-31 $0.64B $0.80B 0.81
2022-09-30 $0.64B $0.72B 0.88
2022-06-30 $0.63B $0.69B 0.92
2022-03-31 $0.64B $0.67B 0.96
2021-12-31 $0.72B $0.62B 1.15
2021-09-30 $0.54B $0.78B 0.69
2021-06-30 $0.51B $0.87B 0.59
2021-03-31 $0.53B $0.93B 0.57
2020-12-31 $0.53B $0.90B 0.59
2020-09-30 $0.57B $0.80B 0.71
2020-06-30 $0.54B $0.75B 0.72
2020-03-31 $0.59B $0.68B 0.87
2019-12-31 $0.54B $0.73B 0.75
2019-09-30 $0.56B $0.67B 0.83
2019-06-30 $0.48B $0.62B 0.77
2019-03-31 $0.48B $0.59B 0.82
2018-12-31 $0.38B $0.59B 0.65
2018-09-30 $0.41B $0.57B 0.72
2018-06-30 $0.37B $0.56B 0.67
2018-03-31 $0.41B $0.51B 0.80
2017-12-31 $0.38B $0.54B 0.70
2017-09-30 $0.42B $0.48B 0.88
2017-06-30 $0.46B $0.45B 1.01
2017-03-31 $0.39B $0.50B 0.77
2016-12-31 $0.36B $0.52B 0.68
2016-09-30 $0.36B $0.49B 0.73
2016-06-30 $0.39B $0.46B 0.85
2016-03-31 $0.40B $0.49B 0.82
2015-12-31 $0.34B $0.51B 0.66
2015-09-30 $0.41B $0.49B 0.84
2015-06-30 $0.41B $0.48B 0.85
2015-03-31 $0.42B $0.48B 0.88
2014-12-31 $0.41B $0.45B 0.91
2014-09-30 $0.44B $0.43B 1.01
2014-06-30 $0.40B $0.44B 0.89
2014-03-31 $0.42B $0.45B 0.95
2013-12-31 $0.45B $0.45B 0.99
2013-09-30 $0.46B $0.43B 1.07
2013-06-30 $0.42B $0.48B 0.87
2013-03-31 $0.42B $0.48B 0.86
2012-12-31 $0.41B $0.45B 0.90
2012-09-30 $0.39B $0.48B 0.82
2012-06-30 $0.38B $0.45B 0.86
2012-03-31 $0.40B $0.43B 0.91
2011-12-31 $0.38B $0.41B 0.92
2011-09-30 $0.39B $0.43B 0.91
2011-06-30 $0.36B $0.49B 0.74
2011-03-31 $0.36B $0.46B 0.77
2010-12-31 $0.37B $0.46B 0.80
2010-09-30 $0.37B $0.53B 0.68
2010-06-30 $0.35B $0.51B 0.69
2010-03-31 $0.36B $0.50B 0.72
2009-12-31 $0.34B $0.48B 0.72
2009-09-30 $0.34B $0.46B 0.75
2009-06-30 $0.34B $0.44B 0.78
2009-03-31 $0.36B $0.42B 0.86
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.208B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00